Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile
Qingnan Zhao(The University of Texas MD Anderson Cancer Center), Shulin Li(The University of Texas MD Anderson Cancer Center)
Cited by 23
Related Papers
EMT, CTCs and CSCs in tumor relapse and drug-resistance
|Oncotarget|2015|464
Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients
|Scientific Reports|2016|195
FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
|Nature Communications|2019|119
WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression
|Nature Communications|2021|56